Results of a Phase II trial of vidutolimod and nivolumab in melanoma
Diwakar Davar • 7 Nov 2022
Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Keep up to date with all the latest news with our monthly newsletter